Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2022

View Archived Issues

New free fatty acid receptor 1 agonists identified at Rezubio Pharmaceuticals

Shanghai Zheye Biotechnology describes new anticancer compounds

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Apoptosis regulator Bcl-2 inhibitors discovered at Beijing Innocare Medical Technology

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Mouse model of SARS-CoV-2 infection shows COVID-19-like disease is dependent on ACE2

STING signaling in beta cells maintains glucose homeostasis

Type II interferon restricts severity of NMO in a new preclinical model

Bryostatin-1 promotes regenerative phenotype within microglia and CNS macrophages

Novel murine model developed to test CNS-penetrant BTK inhibitors

BAFF biomarker tied to severity of allergic rhinitis

Shionogi and Ube collaborate to advance S-337395 toward clinic for RSV

Study identifies potential new bone disease target

Murine model reveals aging to promote autoimmune encephalomyelitis with meningeal inflammation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...